
zzso zzso zzso is a zzso I inhibitor that has increased zzso and zzso activity compared with other zzso I zzso The purpose of this study was to establish a safe dose of zzso given as a weekly zzso infusion 3 of every 4 zzso zzso was administered as a zzso continuous infusion in escalating zzso zzso patients were treated with 81 courses of the zzso zzso zzso included zzso zzso and inability to administer all three doses in the first zzso In minimally zzso patients, a dose of zzso zzso was zzso In patients who were heavily zzso a slightly lower dose, zzso zzso was tolerated without any severe zzso zzso zzso were mild and consisted of mild zzso zzso mild zzso and zzso zzso parameters could be well described with a zzso model in most patients, although the application of the zzso model probably resulted in an underestimated elimination zzso In conclusion, the recommended Phase II dose for zzso administered as a weekly zzso infusion on a zzso week schedule is zzso zzso in minimally zzso patients and zzso zzso in patients who are heavily zzso 

